IMMX Stock Analysis: Buy, Sell, or Hold?
IMMX - Immix Biopharma, Inc. Common Stock
$10.31
-0.37 (-3.46%)
▼
5d:
-6.27%
30d:
+22.01%
90d:
+4.67%
HOLD
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 14, 2026
29d
Get Alerted When IMMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IMMX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMMX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMMX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMMX is currently trading at $10.31, which is considered slightly high relative to its 30-day fair value range of $8.49 to $10.78.
Technical Outlook: Technically, IMMX is in a uptrend. Immediate support is located at $9.60, while resistance sits at $12.14. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: IMMX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.75 (+85.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMMX is in a uptrend. Immediate support is located at $9.60, while resistance sits at $12.14. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: IMMX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.75 (+85.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$8.49 -
$10.78
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 85.0% below Wall St target ($19.75)
- CAUTION: Recommendation downgraded due to -6.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$8.49 -
$10.78
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$9.60
Resistance Level
$12.14
Current Trend
Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.40
Wall Street Target
$19.75
(+85.0%)
Share & Embed Analysis
Last updated: July 15, 2026 11:03 AM ET
Data refreshes hourly during market hours. Next update: 12:03 PM
Data refreshes hourly during market hours. Next update: 12:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 55 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$111 | 60 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 62 BUY |
